BioSpace News Archive

Two placebo-controlled studies published in Cornea show potential for contact lenses to correct vision and reduce occurrence of eye itch from allergies

Promedior, Inc. announced that PRM-151, a novel investigational anti-fibrotic immunomodulator, has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration for Idiopathic Pulmonary Fibrosis.

On Target Laboratories, Inc. announced the appointment of Donna Haire as Executive Vice President of Regulatory and Quality.

Cannabis Growth Opportunity Corporation, a cannabis focused investment corporation with both public and private cannabis holdings, is pleased to report that Vireo Health International Inc., one of the private portfolio holdings commenced trading on the Canadian Securities Exchange, under the symbol “VREO”, on March 20, 2019, at an opening price of $5.65.

New Clinical Trial Adds to Growing Number of Studies Supporting Use of Signatera as a Potential Surrogate Endpoint

BioIQ announced that Richard Popiel, MD, MBA is joining the company as senior advisor.

LP-10, which has received FDA Orphan Drug designation, has now obtained IND approval for Phase-2a, multi-center, double-blind, controlled, clinical trial for hemorrhagic cystitis.

New products for analysis of genes associated with Huntington’s disease and spinal muscular atrophy to be featured

Dicom Systems selected as Enterprise Imaging provider for the largest physician-led and physician-owned radiology practice in the U.S.

Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker